Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional

Lauren J Mills1, Milcah C Scott2, Pankti Shah3

  • 1Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Childhood Cancer Genomics Group, Department of Pediatric, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Bone
|October 31, 2020
PubMed

Insights

Osteosarcoma epigenetics reveal conserved DNA methylation patterns across species. These patterns influence survival and tumor state, offering new therapeutic targets for this aggressive bone cancer.

Area of Science:

  • Oncology
  • Epigenetics
  • Comparative Genomics

Background:

  • Osteosarcoma is an aggressive bone cancer common in adolescents and young adults.
  • It exhibits significant genomic heterogeneity, with TP53 inactivation being a near-universal event.
  • Conserved transcriptional programs linked to survival exist despite varied mutations.

Purpose of the Study:

  • To explore the role of epigenetics, specifically DNA methylation, in osteosarcoma.
  • To compare genome-wide DNA methylation patterns between human and canine osteosarcoma.
  • To link DNA methylation to transcriptional programs and immune cell composition.

Main Methods:

  • Genome-wide DNA methylation profiling of 24 human and 44 canine osteosarcoma samples.
  • Identification of correlated DNA methylation marks across species.
  • Development of a DNA methylation-based immune cell abundance predictor.
  • Analysis of methylation differences in relation to tumor state and cell composition.

Main Results:

  • Identified conserved groups of correlated DNA methylation marks in human and canine osteosarcoma.
  • Linked specific DNA methylation patterns to key transcriptional programs.
  • Established that tumor state, not cell composition, drives DNA methylation differences.
  • Developed a method to estimate immune cell abundance using DNA methylation data.

Conclusions:

  • Genome-wide DNA methylation comparisons across species provide a foundation for understanding conserved epigenetic programs in osteosarcoma.
  • Epigenetic dysregulation plays a significant role in establishing conserved transcriptional programs despite diverse mutational landscapes.
  • This research opens avenues for exploring DNA methylation-based therapeutic strategies for osteosarcoma.